Jan 15 (Reuters) - Arcus Biosciences Inc  RCUS.N :
    * ARCUS BIOSCIENCES PRESENTS PROMISING INITIAL DATA FROM
PHASE 1
PORTION OF ARC-8 STUDY FOR AB680 IN METASTATIC PANCREATIC CANCER
    * ARCUS BIOSCIENCES INC - INITIATED PHASE 1B EXPANSION
PORTION OF
STUDY
    * ARCUS BIOSCIENCES - 41% ORR OBSERVED TO-DATE ACROSS FIRST
FOUR
COHORTS IN PHASE 1 DOSE-ESCALATION PORTION OF ARC-8

Source text for Eikon:  ID:nBw35Gk7za 
Further company coverage:  RCUS.N 

 ((Reuters.Briefs@thomsonreuters.com;))